Praxis in the news
IT consulting and nearshoring
Tamtam found 16 recent articles about Praxis.
- Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
Praxis ended its phase 2 trial early after showing efficacy of its seizure drug relutrigine, preparing for FDA approval discussions targeting severe epilepsy forms.
- Rootstock Acquires Praxis, a Salesforce Consulting Firm
Rootstock Software acquired Praxis Solutions to integrate consulting expertise into its Salesforce-native ERP, improving service and deployment for manufacturers.
- Rootstock strengthens leadership, product and professional services with Praxis acquisition -
Rootstock acquired Praxis to enhance its leadership, product development, and professional services, with Praxis CEO Ohad Idan joining as VP to drive ERP innovation.
- Rootstock Software Acquires Praxis Solutions and Appoints Praxis Head Ohad Idan as Vice President of Product
Rootstock Software acquired Praxis Solutions and appointed its CEO Ohad Idan as VP of Product to enhance its Salesforce-native ERP offerings with AI-driven innovations.
- Praxis: Back From The Dead, Ulixacaltamide Returns In Essential Tremor With Caveats (PRAX)
Praxis's ulixacaltamide shows promise for essential tremor but tolerability and competition limit its use, while epilepsy drugs face market challenges.
- TD Cowen eleva precio objetivo de Praxis Precision Medicines a $251
TD Cowen raised Praxis Precision Medicines' price target to $251 after positive Phase 3 trial results for their essential tremor drug Ulixa and upcoming regulatory milestones.
- Guggenheim eleva precio objetivo de Praxis Precision Medicines a $350 tras datos positivos
Guggenheim raised Praxis Precision Medicines' price target to $350 after positive Phase 3 trial results for their essential tremor drug ulixacaltamida and strong financial positioning.
- Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
Ulixacaltamide demonstrated significant and sustained benefits in essential tremor patients in Phase III trials, with Praxis preparing for FDA talks.
- Praxis se dispara al cumplir sus objetivos un fármaco para el trastorno del movimiento
Praxis Precision Medicines' stock soared after its experimental drug for essential tremor met key study goals, showing sustained patient benefits and minimal side effects.
- Las acciones de Praxis Precision Medicines alcanzan un máximo de 52 semanas a 158,29 dólares
Praxis Precision Medicines' stock surged to a 52-week high amid positive Phase 3 trial results and strategic financial moves, despite recent annual losses.
- Praxis announces planned equity offering after stock nearly triples
Praxis Precision Medicines' stock nearly tripled after positive trial results, prompting a planned equity offering to raise capital.
- Praxis Solutions Expands Leadership Team, Appoints Charlie Shaffer as Chief Revenue Officer to Lead Distribution Growth and AI-Powered Transformation
Praxis Solutions named Charlie Shaffer as Chief Revenue Officer to drive distribution growth and AI-powered transformation in wealth and asset management.
- Praxis lanza Praxis Tech Solutions, propone acelerar digitalización y adopción de IA de empresas desde México
Praxis launched Praxis Tech Solutions to boost AI-driven digital transformation across multiple sectors in Mexico and beyond.
- Estudio RADIANT de Praxis Precision revela prometedores resultados en epilepsia
Praxis Precision Medicines showed promising Phase 2 results for Vormatrigine in epilepsy, with strong seizure reduction and plans for pivotal trials.
- Praxis Tech lanza enrutamiento inteligente con IA para aumentar las tasas de éxito de los pagos
Praxis Tech introduced AI Smart Routing to optimize payment transaction routing, increasing first-try approval rates and reducing costs for merchants.
- Banxico contacta a proveedores; verifica seguridad: Praxis
Banxico is verifying security with SPEI connection providers amid ongoing incidents, with Praxis confirming its clients are secure and highlighting SPEI's advanced security and speed.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Praxis?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies